Health Care Equipment Equities Movers and Shakers - Boston Scientific, Medtronic, Zimmer Holdings, Accuray, and Second Sight Medical Products

LONDON, January 22, 2015 /PRNewswire/ --

Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Medtronic Inc. (NYSE: MDT), Zimmer Holdings Inc. (NYSE: ZMH), Accuray Inc. (NASDAQ: ARAY), and Second Sight Medical Products Inc. (NASDAQ: EYES). Free research report on Boston Scientific can be accessed at http://get.Investor-Edge.com/pdf/?c=Boston%20Scientific&d=22-Jan-2015&s=BSX. The US markets on Wednesday, January 21, 2015, ended on a positive note as the Dow Jones Industrial Average finished at 17,554.28, up 0.22% and the NASDAQ Composite closed at 4,667.42, up 0.27%. The S&P 500 finished the session 0.47% higher at 2,032.12. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 814.90, up 0.11%, with the index advancing 10.82% in the previous three months. Register for your complimentary reports at the links given below.  

Boston Scientific Corp.'s stock edged 0.42% higher, to close the day at $14.39. The stock recorded a trading volume of 7.52 million shares, below its three months average volume of 13.17 million shares. The company's shares oscillated between $14.24 and $14.48 during the session. Over the last one month and over the previous three months, Boston Scientific Corp.'s shares have gained 9.43% and 19.62%, respectively. Further, the stock has advanced 2.93% in the past one year. The stock is trading above its 50-day and 200-day moving averages. Boston Scientific Corp.'s 50-day moving average of $13.37 is above its 200-day moving average of $12.86. Additionally, the stock traded at a PE ratio of 34.16 and has a Relative Strength Index (RSI) of 63.63. Sign up and read the free notes on BSX at:

http://get.Investor-Edge.com/pdf/?c=Boston%20Scientific&d=22-Jan-2015&s=BSX

On Wednesday, shares in Medtronic Inc. recorded a trading volume of 10.79 million shares, higher than its three months average volume of 7.52 million shares. The stock ended the day at $73.06, which was 1.19% above its previous day's closing of $72.20, and registered an intraday range of $71.48 and $73.24. Shares of the company traded at a PE ratio of 18.30. Medtronic Inc.'s shares have gained 1.61% in the previous three trading sessions, 12.43% in the last three months, and 23.06% in the past one year. The stock is trading above its 50-day and 200-day moving averages of $72.55 and $65.15, respectively. Furthermore, shares of Medtronic Inc. have an RSI of 47.06. The complimentary notes on MDT can be downloaded as in PDF format at:

http://get.Investor-Edge.com/pdf/?c=Medtronic&d=22-Jan-2015&s=MDT

Zimmer Holdings Inc.'s stock edged 0.01% lower to end Wednesday's session at $115.88. The stock recorded a trading volume of 0.64 million shares, below its three months average volume of 1.00 million shares. The company's shares fluctuated between $114.92 and $116.56 during the session. Shares of the company traded at a PE ratio of 19.98. Zimmer Holdings Inc.'s shares have rallied 20.15% in the past one year. Further, the stock has gained 0.78% in the previous three trading sessions and 14.37% over the last three months. The stock is trading above its 50-day and 200-day moving averages. Zimmer Holdings Inc.'s 50-day moving average of $113.33 is above its 200-day moving average of $104.39. Additionally, the stock has an RSI of 51.93. Register for free on Investor-Edge and access the latest research on ZMH at:

http://get.Investor-Edge.com/pdf/?c=Zimmer%20Holdings&d=22-Jan-2015&s=ZMH

On Wednesday, shares in Accuray Inc. fluctuated between $6.64 and $6.77 before ending the session 1.03% lower at $6.70. The stock reported a trading volume of 0.27 million shares, much lower than its three months average volume of 0.93 million shares. Although Accuray Inc.'s stock has gained 2.13% in the previous three trading sessions, it has lost 11.14% in the last one month and 8.47% in the past three months. The stock is trading below its 50-day and 200-day moving averages of $7.03 and $7.86, respectively. Moreover, shares of Accuray Inc. have an RSI of 43.96. The complete research on ARAY is available for free at:

http://get.Investor-Edge.com/pdf/?c=Accuray&d=22-Jan-2015&s=ARAY

Shares in Second Sight Medical Products Inc. finished Wednesday's session 6.95% lower at $9.50. A total of 0.50 million shares were traded as the stock vacillated between $9.13 and $10.35 during the session. Over the previous three trading sessions and over the last one month, Second Sight Medical Products Inc.'s shares have declined 7.77% and 15.10%, respectively. Additionally, the stock has an RSI of 46.49. Second Sight Medical Products Inc. had recently launched its IPO and debuted on NASDAQ on November 19, 2014. Free in depth research on EYES is available at:

http://get.Investor-Edge.com/pdf/?c=Second%20Sight%20Medical%20Products&d=22-Jan-2015&s=EYES

About Investor-Edge.com 

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED